Investors have circled back to healthcare stocks this year, and they’re likely to stick around. If they came for the ...

Shares of Merck (NYSE:MRK) traded marginally higher on Friday after falling from a high of $119.38 from the past seven ...

JNJ files for voluntary bankruptcy for the third time. Pfizer withdraws sickle-cell drug drug Oxbryta from worldwide markets.

Pregnant women who do not get enough sleep may be at higher risk of having children with neurodevelopmental delays, a new ...

Beyond acquisitions, we continue to expect steady future dividends, supported by a payout ratio of close to 50% relative to adjusted earnings per share. Patents, economies of scale, and a powerful ...

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses ...

Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Evaxion Biotech (EVAX – Research Report). The ...

As the global population ages, the demand for healthcare services surges, making the sector a promising avenue for long-term ...

Awardees were recognized for developing renewable lubricant base oils and ethyl acetate, more environmentally-friendly ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

The price of ethereum, or 1 ETH, traded at $2,651.51, as of 8 a.m. ET. The highest intraday price that ethereum reached in ...